Pharmacological treatment of neurodegenerative disorders, amyotrophic lateral sclerosis and duchenne muscular dystrophy

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorLe, Huong Quynh Anh
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2021-05-24T14:22:26Z
dc.date.available2021-05-24T14:22:26Z
dc.date.created2018
dc.description.abstractNeurodegenerative disorders are characterized by a gradual dysfunction and loss of neurons and axon in the central nervous system. The clinical features of this diverse group of neurological disorders depend on the particular central nervous system regions involved. The two most common neurodegenerative disorders are Alzheimer’s disease and Parkinson’s disease, after that are amyotrophic lateral sclerosis and Huntington disease. Despite of the increasing prevalence and many efforts of researchers, neurodegeneration disorders still remain mysterious in many aspects which causes many difficulties in clinical approach for treating these diseases. Till date, there’s no definite treatments that can stop or reverse the course of these, so for the time being, we all depend on palliative care to preserve cognitive functions as well as treatment for behavioral changes Duchenne Muscular Dystrophy is a progressive and lethal disease caused by mutations of the dystrophin gene. Currently, DMD is mainly managed with multidisciplinary symptomatic treatment focus on treatment with glucocorticoids and physiotherapy to prevent orthopedic complications.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent68hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/310166
dc.language.isoenhu_HU
dc.subjectAlzheimer's diseasehu_HU
dc.subjectHungtington diseasehu_HU
dc.subjectParkinson's diseasehu_HU
dc.subjectALShu_HU
dc.subjectDMDhu_HU
dc.subjectPharmacotherapyhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titlePharmacological treatment of neurodegenerative disorders, amyotrophic lateral sclerosis and duchenne muscular dystrophyhu_HU
Fájlok